PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin ‑3‑gallate in ovarian cancer.

In conclusion, the results of the present study provided a new underlying mechanism of the effect of EGCG on ovarian cancer and may lead to the development of EGCG as a candidate drug for ovarian cancer therapy. PMID: 32236585 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research